E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/17/2009 in the Prospect News Special Situations Daily.

MedQuist shareholder Costa Brava buys 265,341 shares for 6.3% stake

By Lisa Kerner

Charlotte, N.C., April 17 - MedQuist Inc. investors led by Costa Brava Partnership III, LP bought 265,341 shares of the company's stock between Feb. 24 and April 17 priced from $2.03 to $2.56, it was reported in a schedule 13D/A filed on Friday with the Securities and Exchange Commission.

Costa Brava beneficially owns 2,367,138 shares, or 6.3%, of the Mt. Laurel, N.J., medical transcription technology and services company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.